What does NLS Pharmaceutics Ltd. do?

Jun 22 2025 07:03 PM IST
share
Share Via
NLS Pharmaceutics Ltd. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, with a market cap of USD 8.42 million. It is currently loss-making, with key metrics indicating a negative return on equity and no dividend yield.
Overview:
NLS Pharmaceutics Ltd. operates in the Pharmaceuticals & Biotechnology industry and is classified as a micro-cap company.

Financial Snapshot:
Market cap: USD 8.42 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -1.18
Return on Equity: -265.72%
Price to Book: 5.99

Contact Details:
No Company Details Available.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is NLS Pharmaceutics Ltd. technically bullish or bearish?
Jun 25 2025 09:04 AM IST
share
Share Via
How big is NLS Pharmaceutics Ltd.?
Jun 22 2025 06:15 PM IST
share
Share Via